Skip to main content

AC Meyer

First name:
AC
Last name:
Meyer
Meyer, A. ., Horton, D. ., Neugebauer, N. ., Wooters, T. ., , Dwoskin, L. ., & Bardo, M. . (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033
Meyer, A. ., Rahman, S. ., Charnigo, R. ., Dwoskin, L. ., Crabbe, J. ., & Bardo, M. . (2010). Genetics of novelty seeking, amphetamine self-administration and reinstatement using inbred rats. Genes, Brain, and Behavior, 9(7), 790-8. https://doi.org/10.1111/j.1601-183X.2010.00616.x
, Beckmann, J. ., Meyer, A. ., & Bardo, M. . (2013). Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition. Drug and Alcohol Dependence, 129(3), 240-6. https://doi.org/10.1016/j.drugalcdep.2013.02.024 (Original work published 2013)
Meyer, A. ., Neugebauer, N. ., Zheng, G. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2013). Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal of Neurochemistry, 127(2), 187-98. https://doi.org/10.1111/jnc.12373
, Perry, J. ., Meyer, A. ., Gipson, C. ., Charnigo, R. ., & Bardo, M. . (2014). Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure. Brain Research, 1574, 26-36. https://doi.org/10.1016/j.brainres.2014.06.004 (Original work published 2014)
Meyer, A. ., & Bardo, M. . (2015). Amphetamine self-administration and dopamine function: assessment of gene × environment interactions in Lewis and Fischer 344 rats. Psychopharmacology, 232(13), 2275-85. https://doi.org/10.1007/s00213-014-3854-1
Beckmann, J. ., Meyer, A. ., Pivavarchyk, M. ., Horton, D. ., Zheng, G. ., Smith, A. ., … Dwoskin, L. . (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4
Meyer, A. ., Dua, T. ., Boscardin, W. ., Escarce, J. ., Saxena, S. ., & Birbeck, G. . (2012). Critical determinants of the epilepsy treatment gap: a cross-national analysis in resource-limited settings. Epilepsia, 53(12), 2178-85. https://doi.org/10.1111/epi.12002
Meyer, A. ., Dua, T. ., Ma, J. ., Saxena, S. ., & Birbeck, G. . (2010). Global disparities in the epilepsy treatment gap: a systematic review. Bulletin of the World Health Organization, 88(4), 260-6. https://doi.org/10.2471/BLT.09.064147